CVS Agrees To Pay $315M To Settle Claims Of Allegedly Unlawful Opioid Prescriptions
PROVIDENCE, R.I. — CVS Pharmacy Inc. and certain subsidiaries have agreed to pay $315 million to resolve federal allegations that they violated the False Claims Act (FCA) and the Controlled Substances...To view the full article, register now.
Already a subscriber? Click here to view full article